No cART initiation | Time since cART initiation, <3 months |
Time since cART initiation, ≥3 months | ||||
---|---|---|---|---|---|---|
Baseline characteristics | Cases, N |
HR | Cases, N | HR | Cases, N | HR |
CD4 count, cells/mm3 | ||||||
<100 | 23 | 1 | 13 | 1.02 (0.49–2.13) | 71 | 0.38 (0.19–0.78) |
100 – 200 | 15 | 1 | 4 | 0.58 (0.19–1.77) | 48 | 1.02 (0.39–2.64) |
200 – 350 | 41 | 1 | 6 | 0.90 (0.35–2.31) | 77 | 0.98 (0.56–1.71) |
≥350 | 175 | 1 | 19 | 1.43 (0.84–2.43) | 128 | 0.67 (0.46–0.98) |
HIV-RNA, log10 copies/mL | ||||||
<4 | 92 | 1 | 10 | 1.60 (0.75–3.40) | 69 | 0.74 (0.44–1.24) |
4–5 | 109 | 1 | 15 | 1.11 (0.60–2.04) | 142 | 0.74 (0.49–1.11) |
>5 | 53 | 1 | 17 | 0.97 (0.55–1.73) | 113 | 0.59 (0.29–1.18) |
Age, years | ||||||
< 35 | 91 | 1 | 13 | 1.04 (0.53–2.01) | 87 | 0.56 (0.33–0.95) |
35 – 50 | 119 | 1 | 22 | 1.58 (0.96–2.59) | 181 | 0.82 (0.55–1.23) |
≥50 | 44 | 1 | 7 | 0.65 (0.26–1.66) | 56 | 0.56 (0.27–1.16) |
Sex | ||||||
Male | 216 | 1 | 36 | 1.28 (0.85–1.92) | 276 | 0.68 (0.49–0.93) |
Female | 38 | 1 | 6 | 0.79 (0.31–2.00) | 45 | 0.70 (0.32–1.57) |